Gilead Sciences, Inc
GILD
NASDAQ
Biotechnology
$138.36
USD
+0.22 (+0.16%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $169.87B
Volume 3.4M
Price Target
$155.00 – $170.00
USD
The 4 analysts offering 1-year price forecasts have a max estimate of $170.00 and a min estimate of $155.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$161.25
+$0.7 vs prior
Implied Upside
+16.5%
+0.5% vs prior
Analyst Covering
4
-3 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
36%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$1.25 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
4 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
4 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Joseph Stringer | Needham | Buy | Reiterated | 1 week ago | Plus | Plus | Plus |
Carter Gould | Cantor Fitzgerald | Buy | Reiterated | 1 week ago | Plus | Plus | Plus |
Morten Herholdt | HSBC | Buy | Upgraded | 1 month ago | Plus | Plus | Plus |
Michael Okunewitch | Maxim Group | Buy | Upgraded | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
